Search Results - "Karnes, Jason"

Refine Results
  1. 1

    Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know? by Karnes, Jason H

    Published in Pharmacogenomics (01-12-2018)
    “…Heparin-induced thrombocytopenia (HIT) is a life-threatening, immune-mediated adverse reaction to heparin anticoagulants. The inability to predict HIT…”
    Get full text
    Journal Article
  2. 2

    From Big Data to Precision Medicine by Hulsen, Tim, Jamuar, Saumya S, Moody, Alan R, Karnes, Jason H, Varga, Orsolya, Hedensted, Stine, Spreafico, Roberto, Hafler, David A, McKinney, Eoin F

    Published in Frontiers in medicine (01-03-2019)
    “…For over a decade the term "Big data" has been used to describe the rapid increase in volume, variety and velocity of information available, not just in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Comparison of HLA allelic imputation programs by Karnes, Jason H, Shaffer, Christian M, Bastarache, Lisa, Gaudieri, Silvana, Glazer, Andrew M, Steiner, Heidi E, Mosley, Jonathan D, Mallal, Simon, Denny, Joshua C, Phillips, Elizabeth J, Roden, Dan M

    Published in PloS one (16-02-2017)
    “…Imputation of human leukocyte antigen (HLA) alleles from SNP-level data is attractive due to importance of HLA alleles in human disease, widespread…”
    Get full text
    Journal Article
  5. 5

    Immunopharmacogenomics: Mechanisms of HLA‐Associated Drug Reactions by Deshpande, Pooja, Hertzman, Rebecca J., Palubinsky, Amy M., Giles, Jason B., Karnes, Jason H., Gibson, Andrew, Phillips, Elizabeth J.

    Published in Clinical pharmacology and therapeutics (01-09-2021)
    “…The human leukocyte antigen (HLA) system is the most polymorphic in the human genome that has been associated with protection and predisposition to a broad…”
    Get full text
    Journal Article
  6. 6

    Warfarin Pharmacogenomics in Diverse Populations by Kaye, Justin B., Schultz, Lauren E., Steiner, Heidi E., Kittles, Rick A., Cavallari, Larisa H., Karnes, Jason H.

    Published in Pharmacotherapy (01-09-2017)
    “…Genotype‐guided warfarin dosing algorithms are a rational approach to optimize warfarin dosing and potentially reduce adverse drug events. Diverse populations,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Reply to Non and Chang: Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities by Karnes, Jason H, Schwantes-An, Tae-Hwi, Kittles, Rick, Desai, Ankit A

    “…Karnes et al respond to Non and Chang about challenging the role of genetic ancestry in explaining racial/ethic health disparities in pulmonary arterial…”
    Get full text
    Journal Article
  9. 9

    Role of the gut microbiome in cardiovascular drug response: The potential for clinical application by Steiner, Heidi E., Gee, Kevin, Giles, Jason, Knight, Hayley, Hurwitz, Bonnie L, Karnes, Jason H.

    Published in Pharmacotherapy (01-02-2022)
    “…Response to cardiovascular drugs can vary greatly between individuals, and the role of the microbiome in this variability is being increasingly appreciated…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States by Aljabri, Ahmed, Huckleberry, Yvonne, Karnes, Jason H., Gharaibeh, Mahdi, Kutbi, Hussam I., Raz, Yuval, Yun, Seongseok, Abraham, Ivo, Erstad, Brian

    Published in Blood (29-12-2016)
    “…Despite the availability of multiple nonheparin anticoagulants for the treatment of heparin-induced thrombocytopenia (HIT), few data are available comparing…”
    Get full text
    Journal Article
  12. 12

    Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions by Karnes, Jason H, Miller, Matthew A, White, Katie D, Konvinse, Katherine C, Pavlos, Rebecca K, Redwood, Alec J, Peter, Jonathan G, Lehloenya, Rannakoe, Mallal, Simon A, Phillips, Elizabeth J

    “…Adverse drug reactions (ADRs) are a significant health care burden. Immune-mediated adverse drug reactions (IM-ADRs) are responsible for one-fifth of ADRs but…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Planning and Conducting a Pharmacogenetics Association Study by Hertz, Daniel L., Arwood, Meghan J., Stocco, Gabriele, Singh, Sonal, Karnes, Jason H., Ramsey, Laura B.

    Published in Clinical pharmacology and therapeutics (01-09-2021)
    “…Pharmacogenetics (PGx) association studies are used to discover, replicate, and validate the association between an inherited genotype and a treatment outcome…”
    Get full text
    Journal Article
  15. 15

    Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research Program by Feng, Jianglin, Symonds, Esteban Astiazaran, Karnes, Jason H

    Published in Cancer informatics (01-01-2023)
    “…Epidemiologic evidence for the association of cholesterol and breast cancer is inconsistent. Several factors may contribute to this inconsistency, including…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches by Giles, Jason B, Miller, Elise C, Steiner, Heidi E, Karnes, Jason H

    Published in Frontiers in pharmacology (21-01-2022)
    “…Heparin-induced thrombocytopenia (HIT) is an unpredictable, complex, immune-mediated adverse drug reaction associated with a high mortality. Despite decades of…”
    Get full text
    Journal Article
  20. 20